HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-07-21Clinical Trial Update: Stocrin Re-examination Study (0831-028)
Clinical Trial Update for Stocrin Re-examination Study (0831-028) focusing on HIV infection. The study has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-13Clinical Trial Update: Relative Bioavailability Study of Phase III Tablet Formulation of Cabotegravir [Phase 1]
This clinical trial update reports the completion of a relative bioavailability study for a Phase III tablet formulation of cabotegravir, sp…
-
CLINICAL_TRIALS trial_result · 2015-07-13Clinical Trial Update: Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects [Phase 2]
Phase 2 trial update for HIV treatment-naive subjects evaluating raltegravir plus lopinavir/ritonavir or emtricitabine/tenofovir; study comp…
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women [Phase 1]
This clinical trial update reports on a Phase 1 study exploring HIV entry blockade as a pre-exposure prophylaxis strategy in women.
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers [Phase 1]
Phase 1 clinical trial update evaluating the safety and pharmacokinetics of VM-1500 after multiple oral doses in healthy volunteers, sponsor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients [Phase 3]
Phase 3 trial TMC114-C214 assessed TMC114 (darunavir) with low-dose ritonavir in treatment-experienced HIV-1-infected patients; the study wa…
-
CLINICAL_TRIALS research · 2015-07-01Clinical Trial Update: Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women [NA]
A clinical trial investigating immunity at the genital mucosa in HIV-1 infected and healthy women has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection [Phase 1, Phase 2]
This clinical trial update reports on VM-1500's safety and pharmacokinetics in healthy volunteers, and its safety, tolerability, and antivir…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique [Phase 2]
Phase II clinical trial update reporting safety and immunogenicity of an HIV vaccine regimen using DNA priming with ID Zetajet electroporati…
-
FDA approval · 2015-06-26FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir–ritonavir) from AbbVie Inc. The action relates to the KALETRA product as …
-
FDA approval · 2015-06-26FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine from Aurobindo Pharma Limited, authorizing changes to the generic Zidovudine product …
-
FDA approval · 2015-06-26FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine from Aurobindo Pharma Limited (AP). The approval confirms the availability of a gener…
-
FDA approval · 2015-06-26FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie.
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Evaluation of the Quality of Self-collected Blood Spot Specimens for Laboratory HIV Testing - An InvolveMENt Sub Study
A completed sub-study evaluating the quality of self-collected dried blood spot specimens for laboratory HIV testing within the InvolveMENt …
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial [Phase 4]
The PIONA trial evaluated first-line HIV treatment using a protease inhibitor (PI) or an NNRTI in West Africa. The study is reported as comp…
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Project N-Liten- HIV Prevention for African American Women [NA]
The N-Liten HIV prevention trial, sponsored by Emory University and targeting African American women, has completed. This update notes the s…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa [Phase 4]
A Phase 4 clinical trial evaluating an Aluvia (lopinavir/ritonavir)–based HAART regimen for preventing mother-to-child transmission of HIV i…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Pilot Assessment of Lopinavir/Ritonavir and Maraviroc [Phase 4]
A Phase 4 pilot study evaluating Lopinavir/ritonavir with Maraviroc in HIV/AIDS patients was terminated.
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Internet-Based Sexual Health Education for Middle School Native American Youth [NA]
Completed clinical trial evaluating an internet-based sexual health education program for middle school Native American youth. The study tar…
-
FDA approval · 2015-06-16FDA Approved: NEVIRAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for NEVIRAPINE by Aurobindo Pharma Limited under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: The Navigator Project [NA]
The Navigator Project, a UCSF-sponsored HIV clinical trial, has completed.
-
FDA approval · 2015-06-15FDA Approved: TRIUMEQ — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for TRIUMEQ (abacavir sulfate, dolutegravir sodium, and lamivudine) submitted by ViiV Healthcare…
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Switch From Tenofovir to Raltegravir for Low Bone Mineral Density [Phase 4]
Phase 4 trial results examining switching from tenofovir to raltegravir in people with HIV and low bone mineral density (osteopenia/osteopor…
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs [Phase 3]
The trial offers early access to TMC125 (rilpivirine) for HIV-1 infected patients who have failed multiple antiretroviral regimens. It will …
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
This clinical trial update reports on how different antiretroviral regimens influence immune reconstitution in the female genital tract of H…